About Peter Hofland
Peter Hofland, Ph.D is the Executive Editor of ADC Review/Journal of Antibody-drug Conjugates, a comprehensive digital platform and peer reviewed publication focusing on news and information about innovative therapies such as Antibody-drug Conjugates (ADCs). Hofland contributes articles on the advances in ADCs - from initial discovery to approved drug. He is also a contributor to Onco'Zine and The Onco'Zine Brief.
Onco’Zine, The International Oncology Network (ISSN 2168-5339) is published by Sunvalley Communication, LLC. The journal publishes a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. Onco’Zine is a sponsor-supported, interactive online community for healthcare professionals and other medical specialists involved in the management and care of cancer patients.